0000899243-17-026161.txt : 20171114
0000899243-17-026161.hdr.sgml : 20171114
20171114070122
ACCESSION NUMBER: 0000899243-17-026161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171113
FILED AS OF DATE: 20171114
DATE AS OF CHANGE: 20171114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASADORIAN RAFFI
CENTRAL INDEX KEY: 0001628970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 171198272
MAIL ADDRESS:
STREET 1: TBD
STREET 2: TBD
CITY: TBD
STATE: CA
ZIP: 99999
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-13
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001628970
ASADORIAN RAFFI
C/O ACELRX PHARMACEUTICALS, INC.
351 GALVESTON DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
Chief Financial Officer
Common Stock
2017-11-13
4
P
0
5000
1.9421
A
12000
D
/s/ Martha Adler, Attorney-In-Fact
2017-11-13